Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants

Science

Volumn 285, Issue 5428, 1999, Pages 763-766

  Ramamoorthy, Sammanda ^a   Blakely, Randy D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOZAPINE; COCAINE; DOPAMINE; FENFLURAMINE; IMIPRAMINE; KETANSERIN; MESULERGINE; NISOXETINE; NORADRENALIN; PAROXETINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN INHIBITOR; PROTEIN KINASE C; PSYCHOSTIMULANT AGENT; SEROTONIN; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN TRANSPORTER; VANOXERINE;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; ION TRANSPORT; LIGAND BINDING; NEUROTRANSMITTER UPTAKE; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANTIDEPRESSIVE AGENTS; BIOGENIC MONOAMINES; BIOTINYLATION; CARRIER PROTEINS; CELL LINE; CENTRAL NERVOUS SYSTEM AGENTS; COCAINE; DEXTROAMPHETAMINE; ENZYME ACTIVATION; HUMANS; LIGANDS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; NEUROTRANSMITTER AGENTS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASES; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; TETRADECANOYLPHORBOL ACETATE;

EID: 0033618638     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.285.5428.763     Document Type: Article

References (83)

1. J. Fozzard, Ed., Peripheral Actions of 5-Hydroxytryptamine (Oxford Univ. Press, New York, 1989); H. Y. Meltzer, Ann. N.Y. Acad. Sci. 600, 486 (1990); B. Jacobs and E. C. Azmitia, Physiol. Rev. 72, 165 (1993); W. A. Weiger, Biol. Rev. 72, 61 (1997).
2. J. Fozzard, Ed., Peripheral Actions of 5-Hydroxytryptamine (Oxford Univ. Press, New York, 1989); H. Y. Meltzer, Ann. N.Y. Acad. Sci. 600, 486 (1990); B. Jacobs and E. C. Azmitia, Physiol. Rev. 72, 165 (1993); W. A. Weiger, Biol. Rev. 72, 61 (1997).
3. J. Fozzard, Ed., Peripheral Actions of 5-Hydroxytryptamine (Oxford Univ. Press, New York, 1989); H. Y. Meltzer, Ann. N.Y. Acad. Sci. 600, 486 (1990); B. Jacobs and E. C. Azmitia, Physiol. Rev. 72, 165 (1993); W. A. Weiger, Biol. Rev. 72, 61 (1997).
4. J. Fozzard, Ed., Peripheral Actions of 5-Hydroxytryptamine (Oxford Univ. Press, New York, 1989); H. Y. Meltzer, Ann. N.Y. Acad. Sci. 600, 486 (1990); B. Jacobs and E. C. Azmitia, Physiol. Rev. 72, 165 (1993); W. A. Weiger, Biol. Rev. 72, 61 (1997).
5. S. B. Ross, in Biology of Serotonergic Transmission, N. N. Osborne, Ed. (Wiley, New York, 1982), pp. 160-195; E. L. Barker and R. D. Blakely, in Psychopharmacology: The Fourth Generation of Progress, F. E. Bloom and D. J. Kupfer, Eds. (Raven, New York, 1995), pp. 321-333.
6. S. B. Ross, in Biology of Serotonergic Transmission, N. N. Osborne, Ed. (Wiley, New York, 1982), pp. 160-195; E. L. Barker and R. D. Blakely, in Psychopharmacology: The Fourth Generation of Progress, F. E. Bloom and D. J. Kupfer, Eds. (Raven, New York, 1995), pp. 321-333.
7. R. D. Blakely et al., Nature 354, 66 (1991); B. J. Hoffman, E. Mezey, M. J. Brownstein, Science 254, 579 (1991); S. Ramamoorthy et al., Proc. Natl. Acad. Sci. U.S.A. 90, 2542 (1993); K. P. Lesch, B. L. Wolozin, D. L. Murphy, P. Riederer, J. Neurochem. 60, 2319 (1993).
8. R. D. Blakely et al., Nature 354, 66 (1991); B. J. Hoffman, E. Mezey, M. J. Brownstein, Science 254, 579 (1991); S. Ramamoorthy et al., Proc. Natl. Acad. Sci. U.S.A. 90, 2542 (1993); K. P. Lesch, B. L. Wolozin, D. L. Murphy, P. Riederer, J. Neurochem. 60, 2319 (1993).
9. R. D. Blakely et al., Nature 354, 66 (1991); B. J. Hoffman, E. Mezey, M. J. Brownstein, Science 254, 579 (1991); S. Ramamoorthy et al., Proc. Natl. Acad. Sci. U.S.A. 90, 2542 (1993); K. P. Lesch, B. L. Wolozin, D. L. Murphy, P. Riederer, J. Neurochem. 60, 2319 (1993).
10. R. D. Blakely et al., Nature 354, 66 (1991); B. J. Hoffman, E. Mezey, M. J. Brownstein, Science 254, 579 (1991); S. Ramamoorthy et al., Proc. Natl. Acad. Sci. U.S.A. 90, 2542 (1993); K. P. Lesch, B. L. Wolozin, D. L. Murphy, P. Riederer, J. Neurochem. 60, 2319 (1993).
11. E. Richelson and M. Pfenning, Eur. J. Pharmacol. 104, 277 (1984); J. O. Marcusson, A. Andersson, I. Backstrom, Psychopharmacology 99, 17 (1989); R. W. Fuller and D. T. Wong, Ann. N.Y. Acid. Sci. 600, 68 (1990); R. W. Fuller, Life Sci. 55, 163 (1994); M. Tatsumi, K. Groshan, R. D. Blakely, E. Richelson, Eur. J. Pharmacol. 340, 249 (1997).
12. E. Richelson and M. Pfenning, Eur. J. Pharmacol. 104, 277 (1984); J. O. Marcusson, A. Andersson, I. Backstrom, Psychopharmacology 99, 17 (1989); R. W. Fuller and D. T. Wong, Ann. N.Y. Acid. Sci. 600, 68 (1990); R. W. Fuller, Life Sci. 55, 163 (1994); M. Tatsumi, K. Groshan, R. D. Blakely, E. Richelson, Eur. J. Pharmacol. 340, 249 (1997).
13. E. Richelson and M. Pfenning, Eur. J. Pharmacol. 104, 277 (1984); J. O. Marcusson, A. Andersson, I. Backstrom, Psychopharmacology 99, 17 (1989); R. W. Fuller and D. T. Wong, Ann. N.Y. Acid. Sci. 600, 68 (1990); R. W. Fuller, Life Sci. 55, 163 (1994); M. Tatsumi, K. Groshan, R. D. Blakely, E. Richelson, Eur. J. Pharmacol. 340, 249 (1997).
14. E. Richelson and M. Pfenning, Eur. J. Pharmacol. 104, 277 (1984); J. O. Marcusson, A. Andersson, I. Backstrom, Psychopharmacology 99, 17 (1989); R. W. Fuller and D. T. Wong, Ann. N.Y. Acid. Sci. 600, 68 (1990); R. W. Fuller, Life Sci. 55, 163 (1994); M. Tatsumi, K. Groshan, R. D. Blakely, E. Richelson, Eur. J. Pharmacol. 340, 249 (1997).
15. E. Richelson and M. Pfenning, Eur. J. Pharmacol. 104, 277 (1984); J. O. Marcusson, A. Andersson, I. Backstrom, Psychopharmacology 99, 17 (1989); R. W. Fuller and D. T. Wong, Ann. N.Y. Acid. Sci. 600, 68 (1990); R. W. Fuller, Life Sci. 55, 163 (1994); M. Tatsumi, K. Groshan, R. D. Blakely, E. Richelson, Eur. J. Pharmacol. 340, 249 (1997).
16. S. B. Ross and A. L. Renyi, Acta Pharmacol. Toxicol. 21, 226 (1964); U. V. Berger, X. F. Gu, E. C. Azmitia, Eur. J. Pharmacol. 215, 153 (1992); D. Sulzer, N. T. Maidment, S. Rayport, J. Neurochem. 60, 527 (1993).
17. S. B. Ross and A. L. Renyi, Acta Pharmacol. Toxicol. 21, 226 (1964); U. V. Berger, X. F. Gu, E. C. Azmitia, Eur. J. Pharmacol. 215, 153 (1992); D. Sulzer, N. T. Maidment, S. Rayport, J. Neurochem. 60, 527 (1993).
18. S. B. Ross and A. L. Renyi, Acta Pharmacol. Toxicol. 21, 226 (1964); U. V. Berger, X. F. Gu, E. C. Azmitia, Eur. J. Pharmacol. 215, 153 (1992); D. Sulzer, N. T. Maidment, S. Rayport, J. Neurochem. 60, 527 (1993).
19. G. Rudnick, in Neurotransmitter Transporters: Structure, Function, and Regulation, M. E. A. Reith, Ed. (Humana, Totowa, NJ, 1997), pp. 73-100.
20. S. R. Jones, R. R. Gainetdinov, R. M. Wightman, M. G. Caron, J. Neurosci. 18, 1979 (1998).
21. G. Rudnick and S. C. Wall, Proc. Natl. Acad. Sci. U.S.A. 89, 1817 (1992).
22. A. E. Morgan, B. Horan, S. L. Dewey, C. R. Ashby Jr., Eur. J. Pharmacol. 331, R1 (1997).
23. R. C. Pierce and P. W. Kalivas, J. Neurosci. 17, 3254 (1997).
24. H. Y. Meltzer, R. C. Arora, R. Baber, B. J. Tricou, Arch. Gen. Psychiatry 38, 1322 (1981); S. M. Paul, M. Rehavi, P. Skolnick, J. C. Ballenger, F. K. Goodwin, ibid., p. 1315; M. Stanley, J. Virgilio, S. Gershon, Science 216, 1337 (1982); C. B. Nemeroff et al., Arch. Gen. Psychiatry 45, 919 (1988); M. J. Owens and C. B. Nemeroff, Clin. Chem. 40, 288 (1994).
25. H. Y. Meltzer, R. C. Arora, R. Baber, B. J. Tricou, Arch. Gen. Psychiatry 38, 1322 (1981); S. M. Paul, M. Rehavi, P. Skolnick, J. C. Ballenger, F. K. Goodwin, ibid., p. 1315; M. Stanley, J. Virgilio, S. Gershon, Science 216, 1337 (1982); C. B. Nemeroff et al., Arch. Gen. Psychiatry 45, 919 (1988); M. J. Owens and C. B. Nemeroff, Clin. Chem. 40, 288 (1994).
26. H. Y. Meltzer, R. C. Arora, R. Baber, B. J. Tricou, Arch. Gen. Psychiatry 38, 1322 (1981); S. M. Paul, M. Rehavi, P. Skolnick, J. C. Ballenger, F. K. Goodwin, ibid., p. 1315; M. Stanley, J. Virgilio, S. Gershon, Science 216, 1337 (1982); C. B. Nemeroff et al., Arch. Gen. Psychiatry 45, 919 (1988); M. J. Owens and C. B. Nemeroff, Clin. Chem. 40, 288 (1994).
27. H. Y. Meltzer, R. C. Arora, R. Baber, B. J. Tricou, Arch. Gen. Psychiatry 38, 1322 (1981); S. M. Paul, M. Rehavi, P. Skolnick, J. C. Ballenger, F. K. Goodwin, ibid., p. 1315; M. Stanley, J. Virgilio, S. Gershon, Science 216, 1337 (1982); C. B. Nemeroff et al., Arch. Gen. Psychiatry 45, 919 (1988); M. J. Owens and C. B. Nemeroff, Clin. Chem. 40, 288 (1994).
28. H. Y. Meltzer, R. C. Arora, R. Baber, B. J. Tricou, Arch. Gen. Psychiatry 38, 1322 (1981); S. M. Paul, M. Rehavi, P. Skolnick, J. C. Ballenger, F. K. Goodwin, ibid., p. 1315; M. Stanley, J. Virgilio, S. Gershon, Science 216, 1337 (1982); C. B. Nemeroff et al., Arch. Gen. Psychiatry 45, 919 (1988); M. J. Owens and C. B. Nemeroff, Clin. Chem. 40, 288 (1994).
29. K.-P. Lesch et al., Science 274, 1527 (1996); E. H. Cook Jr. et al., Mol. Psychiatry 2, 247 (1997); K. Y. Little et al., Am. J. Psychiatry 155, 207 (1998); R. A. Furlong et al., Am. J. Med. Genet. 81, 58 (1998).
30. K.-P. Lesch et al., Science 274, 1527 (1996); E. H. Cook Jr. et al., Mol. Psychiatry 2, 247 (1997); K. Y. Little et al., Am. J. Psychiatry 155, 207 (1998); R. A. Furlong et al., Am. J. Med. Genet. 81, 58 (1998).
31. K.-P. Lesch et al., Science 274, 1527 (1996); E. H. Cook Jr. et al., Mol. Psychiatry 2, 247 (1997); K. Y. Little et al., Am. J. Psychiatry 155, 207 (1998); R. A. Furlong et al., Am. J. Med. Genet. 81, 58 (1998).
32. K.-P. Lesch et al., Science 274, 1527 (1996); E. H. Cook Jr. et al., Mol. Psychiatry 2, 247 (1997); K. Y. Little et al., Am. J. Psychiatry 155, 207 (1998); R. A. Furlong et al., Am. J. Med. Genet. 81, 58 (1998).
33. D. Bengel et al., Mol. Pharmacol. 53, 549 (1998); I. Sora et al., Proc. Natl. Acad. Sci. U.S.A. 95, 7699 (1998); B. A. Rocha et al., Nature Neurosci. 1, 132 (1998); F. J. White, Nature 393, 118 (1998); R. R. Gainetdinov et al., Science 283, 397 (1999).
34. D. Bengel et al., Mol. Pharmacol. 53, 549 (1998); I. Sora et al., Proc. Natl. Acad. Sci. U.S.A. 95, 7699 (1998); B. A. Rocha et al., Nature Neurosci. 1, 132 (1998); F. J. White, Nature 393, 118 (1998); R. R. Gainetdinov et al., Science 283, 397 (1999).
35. D. Bengel et al., Mol. Pharmacol. 53, 549 (1998); I. Sora et al., Proc. Natl. Acad. Sci. U.S.A. 95, 7699 (1998); B. A. Rocha et al., Nature Neurosci. 1, 132 (1998); F. J. White, Nature 393, 118 (1998); R. R. Gainetdinov et al., Science 283, 397 (1999).
36. D. Bengel et al., Mol. Pharmacol. 53, 549 (1998); I. Sora et al., Proc. Natl. Acad. Sci. U.S.A. 95, 7699 (1998); B. A. Rocha et al., Nature Neurosci. 1, 132 (1998); F. J. White, Nature 393, 118 (1998); R. R. Gainetdinov et al., Science 283, 397 (1999).
37. D. Bengel et al., Mol. Pharmacol. 53, 549 (1998); I. Sora et al., Proc. Natl. Acad. Sci. U.S.A. 95, 7699 (1998); B. A. Rocha et al., Nature Neurosci. 1, 132 (1998); F. J. White, Nature 393, 118 (1998); R. R. Gainetdinov et al., Science 283, 397 (1999).
38. C. L. Myers and B. R. Pitt, J. Appl. Physiol. 65, 377 (1988).
39. G. M. Anderson and W. C. Horne, Biochim. Biophys. Acta 1137, 331 (1992).
40. J. Launay et al., Am. J. Physiol. 266, 526 (1994); K. J. Miller and B. J. Hoffman, J. Biol. Chem. 269, 27351 (1994); L. D. Jayanthi, S. Ramamoorthy, V. B. Mahesh, F. H. Leibach, V. Ganapathy, ibid., p. 14424; H. Nishio, K. Nezasa, Y. Nakata, Eur. J. Pharmacol. 288, 149 (1995); A. Yura et al., Brain Res. 738, 96 (1996); R. D. Blakely, S. Ramamoorthy, Y. Qian, S. Schroeter, C. Bradley, in Neurotransmitter Transporters: Structure, Function, and Regulation, M. E. A. Reith, Ed. (Humana, Totowa, NJ, 1997), pp. 29-72.
41. J. Launay et al., Am. J. Physiol. 266, 526 (1994); K. J. Miller and B. J. Hoffman, J. Biol. Chem. 269, 27351 (1994); L. D. Jayanthi, S. Ramamoorthy, V. B. Mahesh, F. H. Leibach, V. Ganapathy, ibid., p. 14424; H. Nishio, K. Nezasa, Y. Nakata, Eur. J. Pharmacol. 288, 149 (1995); A. Yura et al., Brain Res. 738, 96 (1996); R. D. Blakely, S. Ramamoorthy, Y. Qian, S. Schroeter, C. Bradley, in Neurotransmitter Transporters: Structure, Function, and Regulation, M. E. A. Reith, Ed. (Humana, Totowa, NJ, 1997), pp. 29-72.
42. J. Launay et al., Am. J. Physiol. 266, 526 (1994); K. J. Miller and B. J. Hoffman, J. Biol. Chem. 269, 27351 (1994); L. D. Jayanthi, S. Ramamoorthy, V. B. Mahesh, F. H. Leibach, V. Ganapathy, ibid., p. 14424; H. Nishio, K. Nezasa, Y. Nakata, Eur. J. Pharmacol. 288, 149 (1995); A. Yura et al., Brain Res. 738, 96 (1996); R. D. Blakely, S. Ramamoorthy, Y. Qian, S. Schroeter, C. Bradley, in Neurotransmitter Transporters: Structure, Function, and Regulation, M. E. A. Reith, Ed. (Humana, Totowa, NJ, 1997), pp. 29-72.
43. J. Launay et al., Am. J. Physiol. 266, 526 (1994); K. J. Miller and B. J. Hoffman, J. Biol. Chem. 269, 27351 (1994); L. D. Jayanthi, S. Ramamoorthy, V. B. Mahesh, F. H. Leibach, V. Ganapathy, ibid., p. 14424; H. Nishio, K. Nezasa, Y. Nakata, Eur. J. Pharmacol. 288, 149 (1995); A. Yura et al., Brain Res. 738, 96 (1996); R. D. Blakely, S. Ramamoorthy, Y. Qian, S. Schroeter, C. Bradley, in Neurotransmitter Transporters: Structure, Function, and Regulation, M. E. A. Reith, Ed. (Humana, Totowa, NJ, 1997), pp. 29-72.
44. J. Launay et al., Am. J. Physiol. 266, 526 (1994); K. J. Miller and B. J. Hoffman, J. Biol. Chem. 269, 27351 (1994); L. D. Jayanthi, S. Ramamoorthy, V. B. Mahesh, F. H. Leibach, V. Ganapathy, ibid., p. 14424; H. Nishio, K. Nezasa, Y. Nakata, Eur. J. Pharmacol. 288, 149 (1995); A. Yura et al., Brain Res. 738, 96 (1996); R. D. Blakely, S. Ramamoorthy, Y. Qian, S. Schroeter, C. Bradley, in Neurotransmitter Transporters: Structure, Function, and Regulation, M. E. A. Reith, Ed. (Humana, Totowa, NJ, 1997), pp. 29-72.
45. J. Launay et al., Am. J. Physiol. 266, 526 (1994); K. J. Miller and B. J. Hoffman, J. Biol. Chem. 269, 27351 (1994); L. D. Jayanthi, S. Ramamoorthy, V. B. Mahesh, F. H. Leibach, V. Ganapathy, ibid., p. 14424; H. Nishio, K. Nezasa, Y. Nakata, Eur. J. Pharmacol. 288, 149 (1995); A. Yura et al., Brain Res. 738, 96 (1996); R. D. Blakely, S. Ramamoorthy, Y. Qian, S. Schroeter, C. Bradley, in Neurotransmitter Transporters: Structure, Function, and Regulation, M. E. A. Reith, Ed. (Humana, Totowa, NJ, 1997), pp. 29-72.
46. Y. Qian et al., J. Neurosci. 17, 45 (1997).
47. J. L. Corey, N. Davidson, H. A. Lester, N. Brecha, M. W. Quick, J. Biol. Chem. 269, 14759 (1994); S. J. Zhu, M. P. Kavanaugh, M. S. Sonders, S. G. Amara, N. R. Zahniser, J. Pharmacol. Exp. Ther. 282, 1358 (1997); S. Apparsundaram, A. Galli, L. J. DeFelice, H. C. Hartzell, R. D. Blakely, ibid. 287, 733 (1998); S. Apparsundaram, S. Schroeter, R. D. Blakely, ibid., p. 744.
48. J. L. Corey, N. Davidson, H. A. Lester, N. Brecha, M. W. Quick, J. Biol. Chem. 269, 14759 (1994); S. J. Zhu, M. P. Kavanaugh, M. S. Sonders, S. G. Amara, N. R. Zahniser, J. Pharmacol. Exp. Ther. 282, 1358 (1997); S. Apparsundaram, A. Galli, L. J. DeFelice, H. C. Hartzell, R. D. Blakely, ibid. 287, 733 (1998); S. Apparsundaram, S. Schroeter, R. D. Blakely, ibid., p. 744.
49. J. L. Corey, N. Davidson, H. A. Lester, N. Brecha, M. W. Quick, J. Biol. Chem. 269, 14759 (1994); S. J. Zhu, M. P. Kavanaugh, M. S. Sonders, S. G. Amara, N. R. Zahniser, J. Pharmacol. Exp. Ther. 282, 1358 (1997); S. Apparsundaram, A. Galli, L. J. DeFelice, H. C. Hartzell, R. D. Blakely, ibid. 287, 733 (1998); S. Apparsundaram, S. Schroeter, R. D. Blakely, ibid., p. 744.
50. J. L. Corey, N. Davidson, H. A. Lester, N. Brecha, M. W. Quick, J. Biol. Chem. 269, 14759 (1994); S. J. Zhu, M. P. Kavanaugh, M. S. Sonders, S. G. Amara, N. R. Zahniser, J. Pharmacol. Exp. Ther. 282, 1358 (1997); S. Apparsundaram, A. Galli, L. J. DeFelice, H. C. Hartzell, R. D. Blakely, ibid. 287, 733 (1998); S. Apparsundaram, S. Schroeter, R. D. Blakely, ibid., p. 744.
51. S. Ramamoorthy, E. Giovanetti, Y. Qian, R. D. Blakely, J. Biol. Chem. 273, 2458 (1998).
52. - (19) and then incubated with prewarmed buffer, with or without 5-HT. The ability of intracellular 5-HT to influence β-PMA-stimulated hSERT phosphorylation was assessed in KRH media by preloading cells at 37° in 10 μM 5-HT for 1 hour, followed by cell washing and application of β-PMA (200 nM), with or without 1 μM 5-HT. For preloading experiments, cells were washed extensively and then lysed, and supernatants were recovered for high-performance lipid chromatography (HPLC) determination of steady-state intracellular 5-HT accumulation in the Neurochemistry Core Facility of the Center for Molecular Neuroscience. HPLC analysis of intracellular 5-HT yielded a value of 200 pmol/500,000 cells. A 10-pl intracellular volume gives an intracellular 5-HT concentration after loading of ∼40 μM.
53. M. Cinquanta et al., Neuropharmacology 36, 803 (1997); D. Crespi, T. Mennini, M. Gobbi, Br. J. Pharmacol. 121, 1735 (1997).
54. M. Cinquanta et al., Neuropharmacology 36, 803 (1997); D. Crespi, T. Mennini, M. Gobbi, Br. J. Pharmacol. 121, 1735 (1997).
55. S. G. Amara and M. J. Kuhar, Annu. Rev. Neurosci. 16, 73 (1993); R. D. Blakely, L. J. DeFelice, H. C. Hartzell, J. Exp. Biol. 196, 263 (1994); G. Rudnick, Methods Enzymol. 296, 233 (1998).
56. S. G. Amara and M. J. Kuhar, Annu. Rev. Neurosci. 16, 73 (1993); R. D. Blakely, L. J. DeFelice, H. C. Hartzell, J. Exp. Biol. 196, 263 (1994); G. Rudnick, Methods Enzymol. 296, 233 (1998).
57. S. G. Amara and M. J. Kuhar, Annu. Rev. Neurosci. 16, 73 (1993); R. D. Blakely, L. J. DeFelice, H. C. Hartzell, J. Exp. Biol. 196, 263 (1994); G. Rudnick, Methods Enzymol. 296, 233 (1998).
58. S. Ramamoorthy and R. D. Blakely, data not shown.
59. B. I. Kanner and S. Schuldiner, CRC Crit. Rev. Biochem. 22, 1 (1987).
60. 32P] incorporation into staurosporine-sensitive PKC substrates using an intact cell paradigm mimicking conditions for SERT labeling (20), but we examined incorporation in cell extracts before immunoprecipitation. 5-HT did not affect PKC activity in cell extracts, nor did 5-HT modulate PKC-dependent phosphorylation of other proteins in intact 293-hSERT cells.
61. N. Sakai et al., J. Neurohem. 68, 2618 (1997).
62. S. Kitayama, T. Dohi, G. Uhl, Eur. J. Pharmacol. 268, 115 (1994); B. J. Copeland, V. Vogelsberg, N. H. Neff, M. Hadjiconstantinou, J. Pharmacol. Exp. Ther. 277, 1527 (1996); L. Zhang, L. L. Coffey, M. E. A. Reith, Biochem. Pharmacol. 53, 677 (1997); Z. B. Pristupa et al., Synapse 30, 79 (1998).
63. S. Kitayama, T. Dohi, G. Uhl, Eur. J. Pharmacol. 268, 115 (1994); B. J. Copeland, V. Vogelsberg, N. H. Neff, M. Hadjiconstantinou, J. Pharmacol. Exp. Ther. 277, 1527 (1996); L. Zhang, L. L. Coffey, M. E. A. Reith, Biochem. Pharmacol. 53, 677 (1997); Z. B. Pristupa et al., Synapse 30, 79 (1998).
64. S. Kitayama, T. Dohi, G. Uhl, Eur. J. Pharmacol. 268, 115 (1994); B. J. Copeland, V. Vogelsberg, N. H. Neff, M. Hadjiconstantinou, J. Pharmacol. Exp. Ther. 277, 1527 (1996); L. Zhang, L. L. Coffey, M. E. A. Reith, Biochem. Pharmacol. 53, 677 (1997); Z. B. Pristupa et al., Synapse 30, 79 (1998).
65. S. Kitayama, T. Dohi, G. Uhl, Eur. J. Pharmacol. 268, 115 (1994); B. J. Copeland, V. Vogelsberg, N. H. Neff, M. Hadjiconstantinou, J. Pharmacol. Exp. Ther. 277, 1527 (1996); L. Zhang, L. L. Coffey, M. E. A. Reith, Biochem. Pharmacol. 53, 677 (1997); Z. B. Pristupa et al., Synapse 30, 79 (1998).
66. H. Bönisch, R. Hammermann, M. Brüss, Adv. Pharmacol. 42, 183 (1998).
67. J. Comeza, M. Casado, C. Gimenez, C. Aragon, Biochem. J. 275, 435 (1991); M. L. Beckman, E. M. Bernstein, M. W. Quick, J. Neurosci. 18, 6103 (1998).
68. J. Comeza, M. Casado, C. Gimenez, C. Aragon, Biochem. J. 275, 435 (1991); M. L. Beckman, E. M. Bernstein, M. W. Quick, J. Neurosci. 18, 6103 (1998).
69. R. A. Huff, R. A. Vaughan, M. J. Kuhar, G. R. Uhl, J. Neurochem. 68, 225 (1997); R. A. Vaughan, R. A. Huff, G. R. Uhl, M. J. Kuhar, J. Biol. Chem. 272, 15541 (1997); S. Apparsundaram and R. D. Blakely, Soc. Neurosci. Abstr. 22, 207.5 (1996).
70. R. A. Huff, R. A. Vaughan, M. J. Kuhar, G. R. Uhl, J. Neurochem. 68, 225 (1997); R. A. Vaughan, R. A. Huff, G. R. Uhl, M. J. Kuhar, J. Biol. Chem. 272, 15541 (1997); S. Apparsundaram and R. D. Blakely, Soc. Neurosci. Abstr. 22, 207.5 (1996).
71. R. A. Huff, R. A. Vaughan, M. J. Kuhar, G. R. Uhl, J. Neurochem. 68, 225 (1997); R. A. Vaughan, R. A. Huff, G. R. Uhl, M. J. Kuhar, J. Biol. Chem. 272, 15541 (1997); S. Apparsundaram and R. D. Blakely, Soc. Neurosci. Abstr. 22, 207.5 (1996).
72. S. Ramamoorthy, H. E. Melikian, V. Qian, R. D. Blakely, Methods Enzymol. 296, 347 (1998). Biotinylation and quantitation of cell surface hSERT expression were carried out as described in (17).
73. N. J. Mabjeesh and B. I. Kanner, Biochemistry 32, 8540 (1993).
74. J.-G. Chen, A. Sachpatzidi, G. Rudnick, J. Biol. Chem. 272, 28321 (1997); J. V. Ferrer and J. A. Javitch, Proc. Natl. Acad. Sci. U.S.A. 95, 9238 (1998).
75. J.-G. Chen, A. Sachpatzidi, G. Rudnick, J. Biol. Chem. 272, 28321 (1997); J. V. Ferrer and J. A. Javitch, Proc. Natl. Acad. Sci. U.S.A. 95, 9238 (1998).
76. A. L. Bauman, S. Ramamoorthy, B. Wadzinski, R. D. Blakely, Soc. Neurosci. Abstr. 24, 440.19 (1998).
77. S. Mager et al., Neuron 12, 845 (1994); L. J. DeFelice and R. D. Blakely, Biophys. J. 70, 579 (1996); H. A. Lester, Y. Cao, S. Mager, Neuron 17, 807 (1996).
78. S. Mager et al., Neuron 12, 845 (1994); L. J. DeFelice and R. D. Blakely, Biophys. J. 70, 579 (1996); H. A. Lester, Y. Cao, S. Mager, Neuron 17, 807 (1996).
79. S. Mager et al., Neuron 12, 845 (1994); L. J. DeFelice and R. D. Blakely, Biophys. J. 70, 579 (1996); H. A. Lester, Y. Cao, S. Mager, Neuron 17, 807 (1996).
80. E. M. Bernstein and M. W. Quick, J. Biol. Chem. 274, 889 (1999).
81. S. E. Hyman, Neuron 16, 901 (1996).
82. 3H]5-HT in the presence of 1 μM paroxetine.
83. We thank E. S. Bush for providing mesulergine, ketanserin, and clozapine, and L. DeFelice and L. Limbird for an initial review of the manuscript. Citalopram was a gift from H. Lundbeck; paroxetine was a gift from SmithKline Beecham. Studies were supported by a National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award to S.R. and by NIH award DA07390 and a NARSAD Established Investigator Award to R.D.B.